Home subcutaneous metoclopramide therapy for hyperemesis gravidarum

被引：12

作者：

Buttino Jr. L. ^{[1
,3
]}

Coleman S.K. ^{[2
]}

Bergauer N.K. ^{[2
]}

Gambon C. ^{[2
]}

Stanziano G.J. ^{[2
]}

机构：

[1] Franciscan Medical Center, Dayton, OH

[2] Matria Healthcare, Inc., Marietta, GA

[3] Maternal Fetal Medicine, Spartanburg, SC 29307, Mary Black

来源：

Journal of Perinatology | 2000年 / 20卷 / 6期

关键词：

D O I：

10.1038/sj.jp.7200398

中图分类号：

学科分类号：

摘要：

OBJECTIVE: To describe the use of subcutaneous (s.c.) metoclopramide in the outpatient treatment of hyperemesis gravidarum. STUDY DESIGN: In a retrospective design, women who received continuous s.c. metoclopramide for treatment of hyperemesis gravidarum were identified from a national database. Data analysis included weight at start and stop of treatment, frequency of resolution of symptoms, and side effects of medication. In addition, data were collected on adjuvant therapies. RESULTS: Between January and December of 1997, there were 646 women with hyperemesis gravidarum who received continuous s.c. metoclopramide on an outpatient basis. A total of 413 patients (63.9%) had complete resolution of symptoms. Seventy-five percent of patients had received one or more antiemetic medications before initiation of s.c. metoclopramide. A total of 192 patients (30.5%) reported at least one side effect related to treatment. The majority of reported side effects were considered mild and did not require discontinuation of s.c. metoclopramide. CONCLUSION: S.c. metoclopramide appears to be a safe, effective treatment for hyperemesis gravidarum. Outpatient treatment may result in decreased costs compared with inpatient hospitalization.

引用

页码：359 / 362

页数：3

共 21 条

[1]

Gadsby R., Barnie-Ashdead A.M., Jagger C., A prospective study of nausea and vomiting during pregnancy, Br J Gen Pract, 43, pp. 245-248, (1993)

[2]

Nageotte M.E., Briggs G.G., Towers C.V., Asrat T., Droperidol and diphenhydramine in the management of hyperemesis gravidarum, Am J Obstet Gynecol, 174, pp. 1801-1806, (1996)

[3]

Cowan M.J., Hyperemesis gravidarum: Implications for home care and infusion therapy, J Intraven Nurs, 19, pp. 46-58, (1996)

[4]

Vellacott I.D., Cooke E.J.A., James C.E., Nausea and vomiting in early pregnancy, Int J Gpaecol Obstet, 27, pp. 57-62, (1998)

[5]

Healthcare Cost and Utilization Project (HCUP). Nationwide Inpatient Sample (NIS) Release 5. Outcomes for 643.13, Hyperemesis with Metabolic Disturbances-Antepartum, (1996)

[6]

Godsey R.K., Newman R.B., Hyperemesis gravidarum: A comparison of single and multiple admissions, J Reprod Med, 36, pp. 287-290, (1991)

[7]

Naef R.W., Chauhan S.P., Roach H., Roberts W.E., Travis K.H., Morrison J.C., Treatment for hyperemesis gravidarum in the home: An alternative to hospitalization, J Perinatol, 15, pp. 289-292, (1995)

[8]

Abell T.L., Riley C.A., Hyperemesis gravidarum, Gastroenterol Clin North Am, 21, pp. 835-849, (1992)

[9]

DiLorio C., The management of nausea and vomiting in pregnancy, Nurse Pract, 13, pp. 23-28, (1988)

[10]

Goodwin T.M., Hyperemesis gravidarum, Clin Obstet Gynecol, 41, pp. 597-605, (1998)

← 1 2 3 →